Abstract | BACKGROUND: fractures may have serious implications in an elderly individual, and fracture prevention may include a careful choice of medications. DESIGN: SETTING: HYVET recruited participants from Eastern and Western Europe, China, Australasia, and Tunisia. SUBJECTS: all participants were > or =80 years of age and hypertensive. METHODS: RESULTS: there were 3,845 participants in HYVET and a total 102 reported fractures (42 in the active and 60 in the placebo group). When taking only validated first fractures, 90 were included in the analyses (38 in the active and 52 in the placebo group). Cox proportional hazard regression, adjusted for key baseline risk factors, resulted in a point estimate of 0.58 (95% CI 0.33-1.00, P = 0.0498). CONCLUSIONS: despite the lowering of blood pressure, treatment with a thiazide-like diuretic and an ACE inhibitor does not increase and may decrease fracture rate.
|
Authors | Ruth Peters, Nigel Beckett, Lisa Burch, Marie-Christine de Vernejoul, Lisheng Liu, Joe Duggan, Cameron Swift, Blas Gil-Extremera, Astrid Fletcher, Christopher Bulpitt |
Journal | Age and ageing
(Age Ageing)
Vol. 39
Issue 5
Pg. 609-16
(Sep 2010)
ISSN: 1468-2834 [Electronic] England |
PMID | 20573778
(Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antihypertensive Agents
- Drug Combinations
- Placebos
- indapamide, perindopril drug combination
- Indapamide
- Perindopril
|
Topics |
- Aged, 80 and over
- Aging
- Antihypertensive Agents
(administration & dosage, adverse effects)
- Blood Pressure
(drug effects)
- Drug Combinations
- Female
- Fractures, Bone
(epidemiology, prevention & control)
- Humans
- Hypertension
(drug therapy, epidemiology)
- Incidence
- Indapamide
(administration & dosage, adverse effects)
- Male
- Perindopril
(administration & dosage, adverse effects)
- Placebos
- Risk Factors
|